psoriasis 🐍 Flashcards
what is psoriasis
immune mediated
chronic
inflammatory (t lymphocytes)
well demarcated
erythematous
silver scaly plaques (hyperproliferation of epidermis)
+ fmh
bimodal age distribution (16-22/55-60)
types of psoriasis (ive seen in clinic)
- chronic plaque psoriasis (persistent & treatment resistent, can be very extensive, on extensor surface, ears, scalp & even beyonf hairline)
- flexural psoriasis (affects the body folds, colonised by candida)- ddx: eczema
- scalp psoriasis (first site usually!!)
- nail psoriasis (nail pitting! onycholysis, a/w inflammatory athritis)
aggravating factors of psoriasis
- strep tonsilitis
- injuries such as cuts or sunburn
- obesity
- stress
- alcohol & smoking
- drugs: anti malarial, NSAIDs, beta blocker, lithium
- stopping oral steroids
associated comorbidities of psoriasis (not sure i understand what this means )
- arthropathy
- IBD
- uveitis
- metabolic syndrome & CVD
- lung fibrosis
how to diagnose psoriasis
it is a clinical diagnosis!!!
how to asssess psoriasis severity?
- What are the assessment tools that are used to assess severity?
- Psoriasis Area and Severity Index (PASI)
- Dermatology Life Quality Index (DLQI)
- Body Surface Area as percentage of total (BSA)
- How is psoriasis severity classified? (everything less than 10%)
- Mild psoriasis: PASI ≤10 and DLQI ≤10 or <10% BSA.
- Moderate psoriasis: (10-30% BSA) to severe psoriasis (>30% BSA): PASI >10 and DLQI >10; involvement of visible areas such as face, palms, soles and/or genitals; severe pruritus and significant nail disease.
non pharmaco tx of psoriasis
- education- dss natural history, tx, ae, cx of psoriasis
- lifestyle modifications: no smoking, no excessive alcohol, BMI
- review effects of medications esp methotrexate
pharmaco for psoriasis
- emollient
- topical steroids- dont exceed >4 weeks
- vit D & retinoid
- purified coal tar for scalp psoriasis
- phototherapy
- (best to avoid) systemic therapy: methotrexate
- for tx resistant severe psoriasis: biologics (adalimumab)
criteria for psoriatic arthropathy
CASPAR
• CASPAR criteria - A patient with an inflammatory musculoskeletal disease (peripheral arthritis, spondylitis, or enthesitis) can be classified as having PsA if a total of at least 3 points is accumulated from the presence of the following list of features (each of which is assigned a certain number of points):
•Skin psoriasis that is:
• -Present - 2 points, OR
• -Previously present by history - I point, OR
• -A family history of psoriasis, if the patient is not affected - one point
•Nail lesions (onycholysis, pitting) - I point
•Dactylitis (present or past, documented by a rheumatologist) - I point
•Negative rheumatoid factor (RF) - I point
•Juxtaarticular bone formation on radiographs (distinct from osteophytes) - I point
• Sensitivity and specificity in four studies, ranging from 9 to 100 percent and 97 to 99 percent, respectively.
PsA
affects DIP
oligoarthritis
symetrical
nail pitting
onycholysis
pitting edema